Tetraspanins, Another Piece in the HIV-1 Replication Puzzle by Suarez, Henar et al.
August 2018 | Volume 9 | Article 18111
Mini Review
published: 03 August 2018
doi: 10.3389/fimmu.2018.01811
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Ken J. Ishii, 
National Institutes of Biomedical 
Innovation, Health and 
Nutrition, Japan
Reviewed by: 
Mickael Mathieu Menager, 
INSERM U1163 Institut 
Imagine, France  
José Mordoh, 
Leloir Institute Foundation 
(FIL), Argentina
*Correspondence:
María Yáñez-Mó  
maria.yannez@uam.es
Specialty section: 
This article was submitted 
to Vaccines and 
Molecular Therapeutics, 







Álvarez S and Yáñez-Mó M (2018) 
Tetraspanins, Another Piece in 
the HIV-1 Replication Puzzle. 
Front. Immunol. 9:1811. 
doi: 10.3389/fimmu.2018.01811
Tetraspanins, Another Piece in  
the Hiv-1 Replication Puzzle
Henar Suárez1, Vera Rocha-Perugini2,3, Susana Álvarez4 and María Yáñez-Mó1,5*
1 Departamento de Biología Molecular, Universidad Autónoma de Madrid, Madrid, Spain, 2 Servicio de Inmunología, Hospital 
de la Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain, 3 Vascular Pathophysiology Research 
Area, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain, 4 Servicio de Inmunobiología Molecular, 
Hospital General Universitario Gregorio Marañón, Madrid, Spain, 5 Centro de Biología Molecular Severo Ochoa, Instituto de 
Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain
Despite the great research effort placed during the last decades in HIV-1 study, still some 
aspects of its replication cycle remain unknown. All this powerful research has succeeded 
in developing different drugs for AIDS treatment, but none of them can completely remove 
the virus from infected patients, who require life-long medication. The classical approach 
was focused on the study of virus particles as the main target, but increasing evidence 
highlights the importance of host cell proteins in HIV-1 cycle. In this context, tetraspanins 
have emerged as critical players in different steps of the viral infection cycle. Through their 
association with other molecules, including membrane receptors, cytoskeletal proteins, 
and signaling molecules, tetraspanins organize specialized membrane microdomains 
called tetraspanin-enriched microdomains (TEMs). Within these microdomains, several 
tetraspanins have been described to regulate HIV-1 entry, assembly, and transfer between 
cells. Interestingly, the importance of tetraspanins CD81 and CD63 in the early steps of 
viral replication has been recently pointed out. Indeed, CD81 can control the turnover of 
the HIV-1 restriction factor SAMHD1. This deoxynucleoside triphosphate triphosphohy-
drolase counteracts HIV-1 reverse transcription (RT) in resting cells via its dual function as 
dNTPase, catalyzing deoxynucleotide triphosphates into deoxynucleosides and inorganic 
triphosphate, and as exonuclease able to degrade single-stranded RNAs. SAMHD1 has 
also been related with the detection of viral nucleic acids, regulating the innate immune 
response and would promote viral latency. New evidences demonstrating the ability of 
CD81 to control SAMHD1 expression, and as a consequence, HIV-1 RT activity, highlight 
the importance of TEMs for viral replication. Here, we will briefly review how tetraspanins 
modulate HIV-1 infection, focusing on the latest findings that link TEMs to viral replication.
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THe CeLLULAR PLASMA MeMBRAne AS THe FiRST 
MODULATOR OF Hiv-1 inFeCTiOn
HIV-1 virus belongs to Lentivirus within the RNA family Retroviridae. It carries two identical 
molecules of positive ssRNA that are converted to dsRNA intermediate by viral RNA-dependent 
DNA polymerase (reverse transcriptase). HIV genome encodes for 16 proteins participating in sev-
eral phases during the HIV life cycle, the structural polyproteins Gag [consisting of matrix, capsid, 
Abbreviations: ADAM, a disintegrin and metalloprotease; CA, capsid; dNTPs, deoxynucleotide triphosphates; ERMs, ezrin, 
moesin, and radixin; ICD, intracellular domain; MA, matrix MA; NC, nucleocapsid; NLS, nuclear localization signal; NPC, 
nuclear pore complex; PIC, pre-integration complex; PIP2, phosphatidylinositol 4,5-biphosphate; RT, reverse transcription; 
RTC, reverse transcription complex; TEMs, tetraspanin-enriched microdomains.
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nucleocapsid (NC), and p6 proteins], Pol (consisting of protease, 
reverse transcriptase, and integrase), and envelope (Env; gp120 
and gp41); regulatory proteins (Tat and Rev); and accessory 
proteins (Vif, Vpr, Vpu/Vpx, and Nef) (1).
The HIV-1 envelope glycoprotein (Env) facilitates viral 
attach ment and entry into host cells (2). Three spikes form the 
Env trimeric complex, each spike consisting of the associa-
tion of a gp120 subunit on the surface and a transmembrane 
gp41 molecule (3). Gp120 interacts with CD4, the cellular 
transmembrane receptor expressed on the membrane of the 
target cell; and this induces a conformational change in gp120 
that exposes new sites for co-receptor binding. There are two 
types of HIV-1 viruses regarding co-receptor preference, 
either CCR5 and/or CXCR4. After this second interaction, 
a hydrophobic region in gp41 is exposed and inserted into the 
plasma membrane, so that viral and cellular membranes get 
close enough to create the fusion pore (2, 4). Besides the recep-
tor and co-receptor, other cell surface molecules expressed on 
dendritic cells (DC) can act as attachment factors, although 
they do not trigger viral fusion. Most attachment factors are 
C-type lectins, or calcium-dependent glycan-binding proteins 
such as DC-SIGN, Siglec-1, mannose, langerin, or DCIR (5–7).
The plasma membrane is not a homogeneous surface but 
contains specialized microdomains that can be differentiated by 
their composition and function: lipid rafts, tetraspanin-enriched 
microdomains (TEMs), caveolae, and clathrin-coated pits 
(8, 9). Lipid rafts, enriched in cholesterol and saturated lipids 
with long hydrocarbon chains and hydroxylated ceramide 
backbones (10–12), provide an environment that favors the 
inclusion of oligomeric proteins such as flotillins and caveolins, 
or proteins with lipid modifications such as palmitoylation or 
GPI anchors (13–15). While lipid rafts properties rely mainly 
on their lipid content, TEMs are organized around protein– 
protein interactions nucleated by tetraspanins (9). Tetraspanins, 
a superfamily of ubiquitous four transmembrane proteins, 
laterally interact with other membrane molecules stablish-
ing specialized domains or platforms called TEMs. The most 
common partners of tetraspanins are integrins, proteins of the 
immunoglobulin superfamily, metalloproteinases, membrane 
receptors, and other tetraspanins (9). TEMs also include cho-
lesterol and gangliosides. Lipid–protein and protein–protein 
interactions are facilitated by multiple palmitoylation sites in 
both tetraspanins and their partners (16).
Given the complex structure of the plasma membrane, it is 
not surprising that the CD4 receptor and CCR5/CXCR4 co-
receptors are not randomly distributed on the cell surface, but 
show a controlled segregation pattern into defined membrane 
clusters (17). This enrichment in specialized microdomains has 
been also reported for attachment factors such as DC-SIGN, 
in the surface of DCs (18). Inclusion of HIV-1 receptors and 
co-receptors in lipid rafts, caveolae microdomains, or TEMs 
tightly regulate viral entry. Since the presence of cholesterol is a 
common feature of these different microdomains, its depletion 
or the use of antibodies that specifically recognize clustered 
cholesterol on the cell surface induces a reorganization of the 
plasma membrane, disrupts receptor clustering and membrane 
dynamics, and inhibits virus entry (19, 20). These antibodies do 
not appear to mask CD4 and CXCR4 interaction sites, but rather 
seem to affect CXCR4 membrane diffusion, triggering an excess 
of CD4-CXCR4 clustering, which prevents proper attachment 
of the viral envelope proteins (19). CD4 and CCR5 co-receptor 
interact with each other under basal conditions, and addition of 
gp120 protein bring them closer (17, 21). Tetraspanins CD81 
and CD82 also associate with the CD4 receptor on T-cells 
(22, 23), and gp120 attachment to CD4 induce co-clustering of 
CD81 (24). CD81 modulates CD4 dimerization and clustering, 
and it decreases CD4 ability to bind to gp120 (25). All these 
results support the notion that membrane microdomains are 
critical regulators of HIV-1 receptors diffusion, allowing proper 
clustering and efficient protein–protein interactions required 
for viral entry (26) (Figure 1B). Under resting conditions, lipid 
rafts and TEMs are mainly independent domains at the cell sur-
face, recognized by the presence of specific markers. However, 
after viral infection, Gag can induce the coalescence of the two 
types of domains (27).
Other studies suggest that these microdomains may also 
be important to regulate receptor recycling and trafficking to 
the plasma membrane. Thus, the tetraspanin CD63 regulates 
CXCR4 expression on the plasma membrane of T-lymphocytes 
and activated B  cells. Moreover, CD63 glycosylation sites are 
critical for the interaction with CXCR4 (28) and promote 
CXCR4 trafficking from the Golgi apparatus to late endosomes 
and lysosomes for its degradation (29, 30) (Figure 1B).
CYTOSKeLeTOn, A SeCOnD BARRieR 
FOR THe viRUS?
Successful HIV-1 entry and infection depends on two sequential 
events, proper clusterization of the CD4 receptor and co-receptors 
after viral attachment, and subsequent polymerization and 
depolimerization of the cortical F-actin meshwork beneath the 
plasma membrane.
Although the cortical actin web was first described as a 
barrier for viral entry (21) (Figure 1A), inhibition of the actin 
nucleation regulator ARP2/3 was shown to inhibit viral Env-
induced fusion, highlighting the importance of an early actin 
polymerization phase that stabilizes viral attachment and sub-
sequent fusion with the plasma membrane (31). In addition, the 
tetraspanin TSPAN7 has been recently identified as an effector 
of actin nucleation (32), necessary for the formation of actin-
rich dendrites in DCs that capture, present, and transfer viruses 
to T-lymphocytes (33), in the process called trans-enhancement 
or trans-infection (Figure 1A).
Gp120 binding to CXCR4 regulates actin dynamics through 
the switch off and on of the actin-binding protein cofilin (21), 
which is inactivated by LIMK-1-dependent phosphorylation, 
promoting actin polymerization and receptor clustering (34). 
LIMK-1 is activated by CXCR4 via two different pathways: 
the Rac1/PAK and the RhoA/ROCK pathways. The activation 
of the latter depends on filamin-A, an actin adaptor protein 
that binds to CD4, CXCR4, and CCR5 (35). Although the 
primary activator of both pathways has not been addressed 
yet, tetraspanins CD82 or CD81 could be good candidates. 
FigURe 1 | Continued
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FigURe 1 | Tetraspanin roles during HIV-1 infection. (A) Tetraspanins regulate transinfection of T-lymphocytes. Dendritic cells stablish contacts with T-lymphocytes 
during antigen presentation. HIV-1 takes advantage of immune synapses to enhance the infection of T-lymphocytes, the main target cells for the virus. This strategy 
is called trans-enhancement or transinfection and takes place through two different pathways. One involves the endocytosis of viral particles by DCs, which  
gives them access to endosomal compartments. As happens with exosomes, viral particles accumulate in multivesicular bodies that finally fuse with the plasma 
membrane releasing those particles together with exosomes into the intercellular space. The second pathway involves TSPAN7, which inhibits viral endocytosis  
and promotes formation of actin rich protrusions in DCs. In this scenario, viral particles are sequestered on the surface of these cells, allowing virus exposure and 
transfer to T-lymphocytes. (B) TEM regulation of HIV-1 entry. CD4 and co-receptors CCR5/CXCR4 segregate within tetraspanin-enriched microdomains (TEMs), 
which control their proper distribution and dynamics enhancing HIV-1 attachment efficiency and subsequent entry. CD63 regulates the expression of CXCR4 on  
the cell surface by stimulating its degradation through the lysosomal pathway. Env binding to its receptor and co-receptor brings them closer and triggers several 
intracellular pathways where actin polymerization is the main response. Active LIMK1 phosphorylates and inactivates cofilin, stimulating actin polymerization. 
Proteins such as moesin or α-actinin have a structural function as they link receptors and tetraspanins to the subcortical actin network. Other proteins such  
as drebrin control the stability of the actin web. TSPAN7 is also a positive regulator of actin polymerization, although the effectors downstream have not been 
addressed yet. (C) HIV-1 assembly occurs at TEMs. Viral protein Gag interacts with the inner leaflet of the plasma membrane via its myristoylation, which  
increases the affinity for cholesterol-enriched areas. Gag also interacts with the positively charged PIP2 and the inner loop of different tetraspanins such as  
CD81 and CD82. Gag induces CD9 clusterization. However, there is no direct evidence indicating an essential requirement for tetraspanins during HIV-1  
budding. Recruitment of all these components into restricted areas may involve the presence of the subcortical actin web for their stabilization, where talin  
and vinculin would act as a link. (D) HIV-1 reverse transcription (RT) is regulated by tetraspanins. SAMHD1 is a negative regulator of viral RT as it decreases  
the concentration of deoxynucleotide triphosphates available in the cell. CD81 regulates SAMHD1 activity by stimulating its degradation via proteasome. CD81 
depletion induces the relocalization of SAMHD1 inside early endosomes. ADAM-10 activity is regulated by tetraspanin TSPANC8 subfamily. The resulting  
intracellular domain when cleaved by a γ-secretase has been identified recently as a component of the PIC. When RT is completed, viral DNA is transported  
into the nucleus where it integrates in the cell genome.
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CD82 can interact with CD4 and regulates actin dynamics in 
both T-lymphocytes and cancer cells through the modulation 
of RhoA and Rac1 signaling (36, 37), while CD81 regulates Rac 
activity turnover (38).
Besides Rho GTPase activity, the membrane lipid phospha-
tidylinositol 4,5-biphosphate (PIP2) facilitates viral infection 
by controlling the activity of several actin-binding proteins 
(31). Among them, ERMs (ezrin, moesin, and radixin), whose 
activation requires the interaction with PIP2 at the plasma 
membrane (39). Gp120 binding to CD4 receptor activates 
moesin, which triggers the reorganization of subcortical F-actin 
and stimulates CD4-CXCR4 clustering in T-lymphocytes (40) 
(Figure 1B). However, other studies performed in Hela cells 
described moesin as a negative regulator of viral infection 
(41), through the control of microtubule stability that could 
affect viral transport to the nucleus (42, 43). Moesin also 
interacts directly with CD81, or indirectly with either CD9 
or CD81 through EWI-2, a TEM component member of the 
immunoglobulin family (44). EWI-2 is also linked to the actin 
cytoskeleton via α-actinin, an actin-binding protein negatively 
regulated by PIP2 that induces a restrictive conformation for 
HIV entry on the cortical actin network (45, 46). Another 
CXCR4 interactor, drebrin, stabilizes actin in a process 
dependent on the viral envelope, so that drebrin silencing 
increases HIV-1 entry again supporting the idea of a need for 
a later actin depolymerization step for viral access into the cell 
(47) (Figure 1B).
This later step of depolymerization is also promoted by CXCR4 
through the activation of cofilin via Gαi signaling (48). Alteration 
in the levels of gelsolin, another actin regulatory molecule, also 
impairs HIV-1 infection (49). In this stage, destabilization of 
the actin network at later phases of viral entry would provide 
access of the virus to microtubules, which will transport the 
RTC [reverse transcription (RT) complex] toward the nucleus 
(31, 50). Studies using nocodazole (an inhibitor of microtubule 
polymerization), or kinesin and dynein inhibitors delay HIV-1 
uncoating and promote the accumulation of viral particles far 
away from the nucleus. Kinesin and dynein may contribute to 
the uncoating process by applying opposite forces that could 
destabilize and disrupt the structure of the capsid while it travels 
through the cytoplasm (51).
Tetraspanins and the actin cytoskeleton are also crucial for 
DC-mediated trans-infection by which the virus is retained at or 
near the cell surface of a DC and transmitted to a T-lymphocyte 
via the close contact of both cells. TSPAN7 expressed in DCs 
is important for the formation of actin rich spikes that are 
able to retain viral particles on their surface (32) (Figure 1A). 
In addition, DCs can trap viral particles in large intracel-
lular vesicles staining for tetraspanins CD81 and CD63 (52), 
although these structures may not be completely closed and 
remain connected with the extracellular space allowing a quick 
release of viral particles (53) during DC–T cell contacts. The 
exosome secretion pathway has been proposed as an alternative 
transmission route between cells without fusion events. Indeed, 
HIV-1 can directly use the endosomal pathway to enter DCs 
and be thereafter released together with exosomes after the 
fusion of multivesicular bodies with the plasma membrane 
(54, 55) (Figure 1A). In addition, recent studies suggest that in 
top of that, exosomes from DC are loaded with molecules that 
could enhance viral replication and release, such as CCR5 or 
CXCR4, which facilitate T-lymphocyte infection, miRNAs or 
viral proteins, such as Nef (56).
Hiv-1 PROMOTeS PLASMA MeMBRAne 
ReMODeLing
Upon successful infection, HIV-1 virus can modify the cell 
surface of infected cells to facilitate the release of new viral 
particles. Vpu and Nef are the viral proteins involved in this 
modulation. Both of them can control CD4 expression at 
the cell surface by different mechanisms. Nef is synthesized 
during the early steps of the infection, interacting with the 
plasma membrane through myristoylation modifications and 
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with the C-terminal domain of the CD4 receptor (57, 58). 
Nef forms a complex with AP-2, promoting CD4 endocytosis 
and subsequent transport to the lysosomal pathway for its 
degradation (59). Nef can also control MHC-I levels to protect 
the infected cell from the immune system, by stimulating its 
endocytosis from the cell surface and by inducing its accu-
mulation at the trans-Golgi network (60). In contrast, Vpu 
is a transmembrane viral protein that is transcribed during 
the late steps of the viral cycle, blocking CD4 transport from 
the endoplasmic reticulum to the membrane and stimulating 
CD4 degradation by the endoplasmic-reticulum-associated 
protein degradation pathway (61).
Tetraspanins CD9, CD81, CD82, CD63, and CD231 are 
included in HIV-1 particles negatively regulating viral infectiv-
ity (62). How the virus regulates their inclusion into virions 
remains unknown, but it does not seem to be an uncontrolled 
process since L6, a transmembrane protein with similar topol-
ogy is excluded (62). Remarkably, HIV-1 viral proteins also 
control tetraspanin expression on the plasma membrane. Vpu 
and Nef downregulate a wide variety of tetraspanins induc-
ing their enrichment at the perinuclear region of the cell 
(63). T-lymphocytes from HIV-1 patients showed a reduced 
expression of CD82 and CD81 (64), while the expression of the 
latter was increased in B-lymphocytes (65). CD81 and CD82 
downregulation was attributed to Vpu, and to a lesser extent 
to Nef. Vpu was shown to directly bind CD81, stimulating 
its degradation by either the proteasome or the lysosomal 
pathways. Although CD82 does not directly interact with Vpu, 
the viral protein also drives its degradation, probably through 
the association with CD81 (63). Therefore, downregulation of 
tetraspanin expression seems to be essential for virus spread. In 
addition, CD81 and CD9 play a negative role in viral-induced 
syncytia formation (24).
Viral assembly and budding is driven by Gag polyprotein, 
which is formed by matrix (MA), capsid (CA), NC, p6 domains, 
and two spacer peptides, named SP1 and SP2 (66) (Figure 1C). 
The initial evidence that suggested that assembly takes place 
in specialized microdomains came from the presence of high 
levels of cholesterol and sphingolipids in the HIV-1 envelope 
(67–69). After synthesis in the cytoplasm, Gag interacts with 
two molecules of viral RNA through its NC domain (70). Gag 
association with the cell surface then is driven by a cluster of 
positive amino acids in the MA domain, with affinity for nega-
tively charged PIP2 in the inner leaflet of the plasma membrane. 
Myristoylation of the N-terminal region of the MA domain 
contributes to its association to membrane areas enriched in 
cholesterol and sphingolipids, like lipid rafts or TEMs (26, 70). 
Env and Gag colocalize with tetraspanins CD63, CD81, and 
CD9 at the plasma membrane of T-cells and direct coimmu-
noprecipitation of CD81 with Gag has been reported (68, 71) 
(Figure 1C). Moreover, in both T-cells and macrophages, there 
is a relocalization of CD63 from intracellular compartments to 
viral assembly sites; however, its depletion does not affect viral 
release (72) (Figure 1C). In macrophages, viral assembly takes 
place in vacuoles that originate from invaginations of the plasma 
membrane (73), and present focal-adhesion-like domains more 
abundant in cells infected with the virus (74). These domains 
are enriched in integrin β2, focal adhesion components, tetras-
panins CD9, CD53, CD81 and CD82, and in PIP2 and AP-2, 
common components of clathrin-coated pits (75). After the 
budding of new virions, Gag is processed by the viral protease 
into the mature proteins enabling the formation of the capsid 
that contains the viral RNA genome and the enzymes needed 
for its replication (10, 70).
Further studies will be required to clarify the specific role of 
tetraspanins during the assembly and budding of new virions. 
All existing evidences support that tetraspanins are located at 
the exit sites and are incorporated in newly formed virions; 
however, future research should decipher whether they are 
functionally important for the organization and recruitment of 
all the components needed for budding (10).
inTRACeLLULAR evenTS OF Hiv-1 
inFeCTiOn ARe SURPRiSingLY ALSO 
DePenDAnT On MeMBRAne 
MiCRODOMAinS
The binding to the viral receptor and co-receptor triggers an 
intracellular response that prepares the host cell for HIV-1 
RT. After the fusion of the viral and the cell membranes, the 
capsid of the virus is released into the cytoplasm. RT occurs in 
a complex called RTC (RT complex), which is formed by viral 
proteins (reverse transcriptase, integrase, matrix protein and 
Vpr), the RNA genome, and host proteins needed to complete 
the cDNA synthesis (3, 76, 77). When the RNA genome is com-
pletely transformed into cDNA, this complex, still composed 
by a combination of viral and cellular proteins, is named PIC 
(pre-integration complex) (78). One surprising component of 
the HIV-1 PIC is the intracellular domain of the transmembrane 
A Disintegrin And Metalloprotease-10 (ADAM10) (79); so, 
when ADAM10 expression is inhibited, a decrease in HIV-1 
RT has been reported (Figure 1D). Tetraspanins could be also 
involved in this event, since ADAM10 localization, trafficking, 
and substrate specificity is regulated by a subfamily of tetraspa-
nins characterized for having eight Cys residues in their large 
extracellular loops (TspanC8) (80) (Figure 1D).
The role of the RTC in the RT process and how the uncoat-
ing process takes place is still a matter of debate. The first 
theory, no longer accepted, proposed that the capsid was 
lost immediately after membrane fusion and viral entry (81). 
Many studies have proven that the capsid is required for the 
RT process since it may provide protection against the host 
cell defense, as well as anchorage for the needed host factors 
(76). Another theory proposes that uncoating takes place while 
the RTC gets to the nucleus. The third one, however, claims 
that the whole capsid might travel along the cytoplasm until 
it reaches the nuclear pore complex where it is disassembled 
(77). There are different pieces of evidence that show that 
the capsid remains stable for some time after viral entry, and 
mutations that increase or decrease the stability of the capsid 
all have a negative effect on HIV-1 infection (81). Most results 
suggest that uncoating may occur during HIV-1 RT (82), and 
it should not involve a complete breakdown of the capsid but 
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a progressive disassembly along the trip through the cytoplasm 
(77). Destabilization of its structure would allow the access 
of the nucleotides, and host proteins needed for the viral RT 
(83). Before nuclear entry, however, the core has to be disrupted 
as it is too large to cross the nuclear pore (82).
Interestingly, some data suggest that membrane-bound 
tetra spanins also regulate after-entry events in HIV-1 infection. 
CD63 has been shown to regulate HIV-1 RT, nuclear transport, 
and integration; however, the mechanisms involved remain 
unsolved (84–86). RT is also modulated by tetraspanin CD81, 
via the regulation of SAMHD1 expression (87). SAMHD1 is a 
deoxynucleoside triphosphate triphosphohydrolase that con-
trols the availability of deoxynucleotide triphosphates (dNTPs) 
through their conversion into deoxynucleoside and inorganic 
triphosphate (88). Recent studies have identified an additional 
role of SAMHD1 in DNA repair and genome stability (89, 90). 
Others suggest that it may also have RNase activity over ssRNA 
or DNA/RNA duplexes (91), although these later results remain 
controversial (92). Because of its relevance, the cell has devel-
oped several mechanisms for SAMHD1 regulation. Related to 
its quaternary structure (93), SAMHD1 monomers associate in 
dimers, and these dimers organize in tetramers. The organization 
of SAMHD1 monomers into the active tetrameric form depends 
on the presence of dNTPs for its stabilization (94). Regarding 
posttranslational modifications, SAMHD1 can be phosphoryl-
ated by cyclin A2/CDK1 at T592 after T cell activation (95), or by 
tyrosine kinases downstream IL-2 and IL-7 stimulation of CD4+ 
T cells (96). These modifications decrease its dNTPase activity, 
increasing viral RT (96). Acetylation at K405 has the opposite 
effect, stimulating SAMHD1 dNTPase activity, and promoting 
the transition from G1 into S phase in cancer cells (97). SAMHD1 
oxidation status is another important regulatory mechanism. 
Three different cysteines of the enzyme can be oxidized, chang-
ing the nucleotide binding site conformation, preventing its 
tetramerization and subsequent activation (98). SAMHD1 has a 
nuclear and cytoplasmic distribution (87, 99). Nuclear localiza-
tion is mainly determined by its NLS sequence (100), and the 
oxidation status seems to be critical for its accumulation in the 
cytoplasm (98). Once in the cytoplasm, tetraspanin CD81 seems 
to regulate the enzyme subcellular localization into endosomes 
(87) (Figure 1D).
SAMHD1 expression levels are also tightly regulated. 
Reduced levels of SAMHD1 increase the amount of dNTPs 
available for viral RT. Thus, SAMHD1 is a major regulator of 
HIV-1 infection as it restricts the availability of dNTPs neces-
sary for HIV-1 RT in resting monocytes, macrophages, CD4+ 
T  cells, and DC. HIV-2 virus, but not HIV-1, expresses an 
accessory protein called Vpx that tags SAMHD1 for its deg-
radation by the proteasome (93, 101). SAMHD1 interaction with 
the C-terminal domain of the tetraspanin CD81 also stimulates 
its proteasomal degradation. Depletion of CD81 abolishes 
SAMHD1 degradation, which is translocated into early endo-
somal compartments where it exerts its dNTPase activity (87) 
(Figure 1D). Although it is reported that HIV-1 downregulates 
CD81 expression at the cell surface (64), this event might only 
occur late in the viral cycle, after RT has been completed.
COnCLUDing ReMARKS
Tetraspanins are important regulators of HIV-1 cycle. They 
would have a dual role in HIV-1 infection. Tetraspanins would 
inhibit infectivity by actively participating in viral entry. They 
would modulate cell surface dynamics and the proper distribu-
tion of receptors and co-receptors, both in the host cell and in 
the viral membrane inhibiting viral entry and induced mem-
brane fusion (24, 62). In contrast, CD81 can enhance viral RT 
by promoting SAMHD1 degradation through the proteasome, 
thus increasing the availability of dNTPs in the host cell (87). 
These opposite functions concur with a first round of active 
viral entry and replication to produce new viral particles in 
the cell, followed by a second round of viral latency to avoid 
recognition by the immune system so it can persist within the 
organism (102). HIV-1 possesses the tools to control tetraspanin 
expression by the host cell, avoiding undesirable effects on viral 
infection. As important membrane organizers, tetraspanins 
regulate multiple cellular proteins that control the different 
steps of HIV-1 infection cycle, and thus represent an interesting 
target for the development of new drugs against viral infection. 
Finally, it has been reported that peptides against the intracel-
lular region of CD81 can block its activity over SAMHD1 and 
reduce viral RT (87). This result leaves open the possibility of 
using specific peptides against tetraspanins as an interesting 
strategy to restrict HIV-1 infection.
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